NCT04400422View on ClinicalTrials.gov

Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

September 20, 2018

Study Completion Date

September 20, 2018

Conditions
Fatty Acid Oxidation Disorder
Interventions
DIETARY_SUPPLEMENT

Lipano formula

Subjects will be asked to take an MCT infant formula to assess the tolerability, compliance and overall acceptability of the product for patient with LCHAD

Trial Locations (1)

117513

Russian Children's Hospital Center for Orphan Diseases, Moscow

All Listed Sponsors
lead

Dr. Schär AG / SPA

INDUSTRY

NCT04400422 - Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders | Biotech Hunter | Biotech Hunter